Entity

FDA

FDA — U.S. Food and Drug Administration. The U.S. regulator that approves drugs, medical devices, and food safety.

As of 31 Oct 2026Last evidence 30 Oct 2026

What is happening now

  • FDA Advisory No.2026-1681 || Public Health Warning Against the Purchase and Use of the Unregistered Medical Device Product “FIRST LINE FINGERTIP PULSE OXIMETER (YK-84C)”

    Reported claim · first reported 28 Oct 2026 · 1 claim · best-carried claim: 2 separate publishers

  • FDA Grants Breakthrough Device Designation to Pharaoh Neuro's Neurapheresis™ CSF Management System

    Reported claim · first reported 28 Oct 2026 · 1 claim · best-carried claim: 1 separate publisher

  • STAT+: FDA offers new details on quicker approval pathway for personalized gene therapies

    Reported claim · first reported 27 Oct 2026 · 1 claim · best-carried claim: 2 separate publishers

  • FDA Warning: Two Lots of Darwin’s Natural Pet Products Cat Food Test Positive for Salmonella

    Reported claim · first reported 27 Oct 2026 · 1 claim · best-carried claim: 2 separate publishers

  • FDA approves talazoparib with enzalutamide for metastatic androgen pathway modulation-naïve or -sensitive prostate cancer with HRR gene mutations

    Reported claim · first reported 26 Oct 2026 · 1 claim · best-carried claim: 4 separate publishers

All 7 events and claims involving FDA

What changed

  • Attention Fading: 153 mentions on 31 Oct 2026, against 167 on 10 Oct 2026 (-8%).
  • State Last recorded change: coverage state went from steady to rising on 29 Oct 2026 (3 changes recorded since 19 Oct 2026).
  • Claims No claim first reported since 30 Oct 2026.

How well we know this

2,911 documents · 244 publishers · 35% contain a typed assertion · last evidence 30 Oct 2026

  • Gap: assertion coverage 0.349: about 65% of mentions carry no typed assertion
  • Gap: 3 receipts withheld: no source link (the same rule the topic record applies)

In this snapshot’s daily coverage:

Reported alongside FDA

Names most often reported alongside it; bigger circles and heavier lines mean more shared documents. A dashed circle has no page of its own yet.

United StatesAIChina
  • Drug Administration · 980 shared documents · no page of its own yet
  • U.s. Food · 392 shared documents · no page of its own yet
  • United States · 375 shared documents
  • Clinical Trials · 361 shared documents · no page of its own yet
  • AI · 357 shared documents
  • Clinical Trial · 336 shared documents · no page of its own yet
  • Fda-Approved · 262 shared documents · no page of its own yet
  • Public Health · 239 shared documents · no page of its own yet
  • China · 233 shared documents
  • Weight Loss · 169 shared documents · no page of its own yet

Story momentum

Fading

The word compares 153 mentions on 31 Oct 2026 with 167 on 10 Oct 2026 (-8%); a change of less than 8% either way reads Steady.

Daily mentions +96% from 16 Sept 2026 to 31 Oct 2026, between 10 and 171 a day

How often tracked coverage mentions FDA, day by day.

Market price, cited

Not priced yet

No open prediction market prices a question materially about FDA yet. Ask about FDA

No market price on file: no prediction market prices a question about this name yet

Coverage volume and market price are separate measures.

On the desk: Health & Bio Desk

For developers

This page is also an object: GET https://sigb.ai/api/v1/node/e/1ccaf7a7b68e32af55cbc6a4 returns the same record as sb.node.v1. Or call the get_entity MCP tool at https://sigb.ai/api/mcp with name fda.

{
  "name": "fda",
  "label": "FDA",
  "asOf": "2026-10-31",
  "mentions": 153,
  "domains": 35,
  "node": {
    "id": "sb:e/1ccaf7a7b68e32af55cbc6a4",
    "schema": "sb.node.v1",
    "rest": "https://sigb.ai/api/v1/node/e/1ccaf7a7b68e32af55cbc6a4",
    "knowledgeCutoff": "2026-10-31T15:48:13.617794+00:00",
    "snapshot": "this deploy's committed data files (commit not exposed in this runtime)"
  },
  "coverageTrend": "fading",
  "history": {
    "since": "2026-10-19T15:50:53.270508+00:00",
    "changes": 3
  },
  "whereFrom": {
    "level": "counts",
    "label": "153 mentions across 35 domains",
    "children": [
      {
        "level": "reports",
        "label": "5 reports drawn on this page, each with its link",
        "children": {
          "count": 5,
          "unfold": "expand=+1"
        }
      },
      {
        "level": "domains",
        "label": "35 coverage domains",
        "children": {
          "count": 18,
          "unfold": "expand=+1"
        }
      },
      {
        "level": "not shown",
        "label": "The other 148 mentions",
        "edge": "counted daily from tracked coverage; single mentions are not listed one by one"
      }
    ]
  }
}

The figures on this page, as data. The tool returns the full entity record.

Events involving FDA

Most-reported first, then newest. Registered events come from the event record; reported events are groups of claims about one occurrence. Claims are grouped when they were first reported within 2 days of each other and either name at least 2 of the same people, places or things besides this one, or share at least 25% of their wording. Each claim keeps its own record.

  • FDA Advisory No.2026-1681 || Public Health Warning Against the Purchase and Use of the Unregistered Medical Device Product “FIRST LINE FINGERTIP PULSE OXIMETER (YK-84C)”

    Reported claim · first reported 28 Oct 2026 · 1 claim · best-carried claim: 2 separate publishers

    single source

  • FDA Grants Breakthrough Device Designation to Pharaoh Neuro's Neurapheresis™ CSF Management System

    Reported claim · first reported 28 Oct 2026 · 1 claim · best-carried claim: 1 separate publisher

    single source

  • STAT+: FDA offers new details on quicker approval pathway for personalized gene therapies

    Reported claim · first reported 27 Oct 2026 · 1 claim · best-carried claim: 2 separate publishers

    single source

  • FDA Warning: Two Lots of Darwin’s Natural Pet Products Cat Food Test Positive for Salmonella

    Reported claim · first reported 27 Oct 2026 · 1 claim · best-carried claim: 2 separate publishers

    could not check

  • FDA approves talazoparib with enzalutamide for metastatic androgen pathway modulation-naïve or -sensitive prostate cancer with HRR gene mutations

    Reported claim · first reported 26 Oct 2026 · 1 claim · best-carried claim: 4 separate publishers

    corroborated

  • fda approved over-the-counter weight loss drugs 2026

    Reported claim · first reported 25 Oct 2026 · 1 claim · best-carried claim: 3 separate publishers

    could not check

  • Regulatory approval: FDA

    Registered event · reported 6 Oct 2026 to 22 Oct 2026 · claims are not yet placed under registered events

    Open event

Walk the record from FDA

Open where it comes from, follow a claim or a related name, and use the trail to come back. Every step says what it is, how it stands and when. Machines read the same record.

FDA

Entity.

Evidence
2,911 documents · 244 separate publishers · a mention shows the name is in use, not that any claim about it is true
Standing
A name from our starting list; its record is kept up to date automatically from coverage
Time
first seen 6 Apr 2026, last seen 30 Oct 2026
Measured
35% of mentions say something specific about it; the rest only name it
As of
31 Oct 2026
17 links from here

Who it moves with: the 10 names are in the map above.

What is claimed about it (6)

  • Corroborated: Reported by three or more sources that did not copy each other.
  • Single source: Reported by one source so far.
  • Could not check: We could not count this claim's sources, so we do not say how well it is supported.

Situations it is named in (1)

For machines: this record as JSON

Watch this

What the coverage says

Recent reporting that names FDA, newest first. Open any row to follow it to the original article.

1 more headline counted but not shown: no source link on file

Evidence tiers: primary source = an official public record · attributed = a named outlet, receipt linked · lead = observed, not yet receipted.

What it connects to

Related records.

Recorded history

  • 29 Oct 2026

    coverage state changed: steady to rising

    Previous state held since 28 Oct 2026

  • 28 Oct 2026

    coverage state changed: rising to steady

    Previous state held since 24 Oct 2026

  • 24 Oct 2026

    coverage state changed: steady to rising

    Previous state held since 18 Oct 2026

3 changes recorded since 19 Oct 2026, newest first.

Ask about FDAWatch FDA

Story momentum counts mentions in tracked coverage. Prices are the market’s own, cited with the venue. Informational only, not advice. As of 31 Oct 2026.